Westin Immunogenicity Seminar 2011
Tuesday, September 27, 2011
9:45 am – 6:10 pm
Kiri Room
The Westin Tokyo
1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan
Speakers:
Annie De Groot M.D.
Director and Professor, Institute of Immunology and Informatics,University of Rhode Island and CEO/CSO EpiVax;
Frances Terry, Immunoinformatics / Bioinformatics Specialist, EpiVax, Inc.
Keizo Yoshida Ph.D., EpiVax Asia
9: 00 – 9 :45 AM Registration / Breakfast 9: 45 AM Opening Remarks – Keizo Yoshida, Ph.D. 10: 00 AM Immunogenicity: Determinants and Correlates – A. S. De Groot M.D. 11:15 AM –Morning Break – Coffee / Tea 11: 30 AM Case Studies – Predicting and Confirming Immunogenicity – A.S. De Groot M.D. 12: 30 PM — Lunch Provided 1: 00 PM ISPRI Demonstration – Frances Terry, EpiVax 1: 45 PM iVAX Demonstration – Frances Terry, EpiVax 2: 30 PM Recent Tregitope Data: Application to Protein Medicine – A.S. De Groot M.D 3: 30 PM Afternoon Break – Coffee / Tea 5: 00 PM FDA and EMEA discussions – Interpreting the guidelines – A.S. De Groot M.D 6: 00 PM Closing Remarks – Keizo Yoshida, Ph.D., EpiVax Asia |
To register for the seminar, contact CMillerIV[at]EpiVax.com or YoshidaKeizo@gmail.com
For more information on Tregitopes, please see this link: https://tinyurl.com/EpiVax-AAPS-Award and also this link for the original paper: https://tinyurl.com/ASDeGroot-Blood-2008 and here for the relevance to protein medicine: https://tinyurl.com/ASDeGroot-Clin-Immunol-2009